in utero progestin exposure congenital malformations, progesterone pregnancy safety birth defects, 17 alpha-hydroxyprogesterone caproate fetal safety, progestin exposure offspring congenital anomalies cohort study, Resseguie progestin exposure Olmsted County, exogenous progesterone pregnancy teratogenicity, prenatal progestogen exposure birth outcomes, hydroxyprogesterone caproate safety pregnancy malformations, progestin versus androgenic progestin fetal effects, progesterone supplementation pregnancy fetal anomalies epidemiology
PMID 3987922 3987922 DOI 10.1016/s0015-0282(16)48490-6 10.1016/s0015-0282(16)48490-6
Keywords
17 alpha-Hydroxyprogesterone Caproate, Abnormalities, Drug-Induced/epidemiology, Ethisterone/adverse Effects, Female, Fetal Death/epidemiology, Humans, Hydroxyprogesterones/adverse Effects, Infant, Newborn, Male, Maternal-Fetal Exchange, Medroxyprogesterone/adverse Effects, Minnesota, Norethindrone/adverse Effects, Pregnancy, Prenatal Exposure Delayed Effects, Progesterone/adverse Effects, Progestins/adverse Effects, Hydroxyprogesterones, Progestins, 17 alpha-Hydroxyprogesterone Caproate, Progesterone, Medroxyprogesterone, Ethisterone, Norethindrone